With the emergence of heavily polluted megacities, exposure to the common air pollutant ozone (O 3 ) is a global respiratory health problem. O 3 is an important trigger of asthma exacerbation, [1] [2] [3] but the underlying pathways remain unclear. O 3 -induced inflammatory changes occur acutely, and clinical symptoms can last up to a week in asthmatic patients. 4 The effects of O 3 involve activation of the pulmonary epithelium and innate immune system, with release of IL-6 and IL-8 followed by influx of neutrophilic granulocytes. In both asthmatic patients 5, 6 and mouse models of allergic airway inflammation, 7 O 3 also elicited IL-5 release within hours of exposure. IL-5 is classically considered one of the T H 2 cell-derived cytokines released together with IL-4 and is responsible for eliciting airway eosinophilia, a cardinal pathologic feature of asthma. 8, 9 In our previous studies IL-5 appeared without detectable levels of IL-4 in the airways within a few hours of O 3 exposure, 7 suggesting an early source of IL-5 during the inflammatory airway response distinct from T H 2 cells.
Lung-resident group 2 innate lymphoid cells (ILC2s) 10 are recently described innate lymphocytes with a capability to release IL-5 and IL-13 in response to IL-33 without antigenic stimulation and to initiate and perpetuate allergic airway inflammation. ILC2s reside in adipose tissues and at various barrier mucosal sites in the intestine and lung. During influenza virus infection, ILC2s accumulate and mediate virus-induced airway hyperresponsiveness (AHR), as well as epithelial repair. 11, 12 Lung ILC2s also promote acute airway eosinophilia in mice exposed to the protease papain or the fungal allergen Alternaria species. [13] [14] [15] [16] [17] The function of ILC2s appears to be evolutionarily conserved because human ILC2s also produce T H 2 cytokines in response to IL-33 and IL-25 similarly to mouse ILC2s. 3, 11, 18, 19 We hypothesized that activation of lung-resident ILC2s could contribute to the rapid inflammatory changes elicited by O 3 exposure in mice.
METHODS Mice
All experimental animals used in this study were housed under pathogen-free conditions. Experiments were performed on male mice between 8 and 12 weeks 
O 3 exposure and allergen challenge protocols
Allergen sensitization/challenge and O 3 exposure were carried out, as previously described. 7 Briefly, mice were sensitized with intraperitoneal injections of 20 mg of Aspergillus fumigatus mixed with alum on days 0 and 7 and received an intranasal challenge with 25 mg of A fumigatus on day 13. Mice were exposed to air or O 3 (3 ppm) or to forced air for 2 hours on day 16 and were killed 12 hours after O 3 exposure on day 17. When mice were exposed to O 3 or forced air alone, unless otherwise indicated, they were studied 12 hours after the exposure ended. This time point was selected based on pilot time-course studies to represent the height of proinflammatory changes, as seen in BALB/c mice. The chosen level of O 3 exposure in our studies was based on numerous previously published works on mice, rats, and human subjects by other laboratories and ours. The 3-ppm O 3 dose represents a level of exposure that is well tolerated by both BALB/c and C56BL/6 mice and that causes a significant airway inflammatory response. That a 3-ppm inhaled dose in rodents results in O 3 concentration in the lungs relevant to human exposure levels has been experimentally also validated by others by using oxygen-18-labeled O 3 ( 18 O 3 ). For example, in a study by Hatch et al, 21 it was demonstrated that exposure to 18 O 3 (0.4 ppm for 2 hours) caused 4-to 5-fold higher 18 O 3 concentrations in human subjects than in rats. Rats exposed to 2.0 ppm had still less 18 O 3 in bronchoalveolar lavage (BAL) fluid than human subjects exposed to 0.4 ppm. The mechanisms underlying the species discrepancies in the recoverable O 3 levels in the lung are not entirely clear. Slade et al 22 demonstrated that after exposure to O 3 , mice react with a rapid decrease of core temperature in a strain-specific manner. The recoverable 18 O 3 level in lung tissue was negatively associated with the extent of hypothermia that significantly altered O 2 consumption and pulmonary ventilation, explaining at least in part the interspecies differences seen in O 3 susceptibility.
BAL was performed and cells were assessed on cytospin preparations stained with Diff-Quik (Thermo Scientific, Florence, KY). Mice were compared for total and differential BAL cell counts by using a Countess Automated Cell Counter (Life Technologies, Grand Island, NY) and cytospin counts. In other experiments BAL was also processed for fluorescenceactivated cell sorting (FACS) analysis. Lungs were perfused and removed for isolation of ILC2s and RNA extraction. The BAL fluid supernatant was processed for ELISA for measurement of IL-4 and IL-5 expression.
Immunoglobulin treatment, isolation of lung hematopoietic cells, and adoptive transfer Four doses of anti-Thy1.2 mAb (30H12; BioXCell, West Lebanon, NH) and anti-CD4 mAb (GK1.5; BD Biosciences, San Jose, Calif) were administered intraperitoneally every other day (0.5 mg per mouse) to deplete ILC2s. For FACS analysis and ILC2 isolation, mice were exsanguinated, and lungs were perfused by injecting 10 mL of PBS into the right ventricle of the heart. Lungs were carefully cut into small fragments and digested in HBSS containing 0.025 mg/mL Liberase D (Roche Diagnostics, Mannheim, Germany) and 10 U/mL DNase I (Roche Diagnostics). Cells were filtered with a cell strainer. For adoptive transfer, lung ILC2s were isolated from Thy1.1 mice by means of FACS sorting and grown with IL-2, IL-7, and IL-33 for 7 days. Cells (10 6 ) were intratracheally transferred into anti-Thy1.2 mAb-treated Thy1.2 mice.
Flow cytometry and cell sorting
Antibodies were purchased from eBioscience (San Diego, Calif) unless specified otherwise. The anti-lineage (Lin) mixture included anti-FcεR (MAR-1), anti-B200 (RA3-6B2), anti-CD19 (ID3), anti-Mac-1 (M1/70), anti-Gr-1 (8C5), anti-CD11c (HL3), anti-NK1.1 (PK 136), anti-Ter-119 (Ter-119), anti-CD3 (2C11), anti-CD8b (53.5.8), anti-T-cell receptor b (H57), and anti-gd T-cell receptor (GL-3). We also used anti-Thy1.2 (53-2.1), anti-Siglec-F (E50-2440; BD Biosciences), and anti-ST2 (DJ8; MD Bioproducts, St Paul, Minn). Cell sorting was performed on a FACSAria II (BD Biosciences), and flow cytometric analysis was performed on an LSR II Flow Cytometer (BD Biosciences).
Cytokine assessment
BAL fluid IL-4 and IL-5 expression was measured by using a standard sandwich ELISA (eBioscience), according to the manufacturer's protocol. Total mRNA and protein were extracted from perfused lung tissue. In the O 3 time course experiments, Il33 mRNA was measured as part of an Affymetrix GeneChip Microarray (Affymetrix, Santa Clara, Calif). IL-33 protein was assessed as part of a Luminex assay (Luminex, Auston, Tex). For comparison of BALB/c and C57BL/6 lung Il33 mRNA, lung tissue was obtained and total RNA was extracted 12 hours after air or O 3 exposure, and quantitative PCR (qPCR) was performed. ILC2s and CD4 T cells were FACS sorted, total RNA was extracted, and cytokine mRNA expression was examined by using qPCR.
Lung function measurements
AHR to aerosolized acetyl-b-methylcholine chloride methacholine inhalation was assessed by using the flexiVent system (SCIREQ, Montreal, Quebec, Canada), as described previously. 23 Briefly, lung mechanics were studied in tracheostomized mice after achievement of anesthesia by means of intraperitoneal injection of ketamine and xylazine. Mice were ventilated with a tidal volume of 8 mL/kg at a rate of 150 breaths/min and a positive end-expiratory pressure of 2cm H 2 O by using a computerized flexiVent System. After mechanical ventilation for 2 minutes, a sinusoidal 1-Hz oscillation was applied to the tracheal tube. The single-compartment model was fitted to these parameters by using multiple linear regression to calculate dynamic resistance, compliance, and tissue damping of the airway. Baseline measurements and responses to aerosolized saline were followed by measurements of responses to increasing doses of 0.625 to 25 mg/mL of aerosolized methacholine (Sigma-Aldrich, St Louis, Mo). Recorded values were averaged for each dose and used to obtain dose-response curves for each mouse.
Statistical analysis
Data were expressed as means 6 SEMs. All data were analyzed with GraphPad Prism 5 software, (GraphPad Software, San Diego, Calif). Multiple-group comparisons were made by using 1-way ANOVA, followed by the Bonferroni correction. Differences between groups in methacholine responsiveness were assessed by using 2-way ANOVA.
RESULTS O 3 exposure enhanced A fumigatus-induced eosinophilia in BALB/c but not C57BL/6 mice To model exacerbation of allergic airway changes (as seen in asthmatic patients on O 3 inhalation), we used a combined allergen sensitization/challenge and O 3 exposure protocol. 7 In this model mice were sensitized with intraperitoneal injections of A fumigatus mixed with alum on days 0 and 7 and received an intranasal challenge with A fumigatus on day 13. Mice were exposed to O 3 or forced air for 2 hours on day 16 and killed 12 hours later on day 17 (Fig 1, A) . A fumigatus induced eosinophilic airway inflammation and O 3 induced airway neutrophilia, whereas the combination of these treatments elicited appearance of both eosinophils and neutrophils in the airways (Fig 1, B) . Quantitation of the changes revealed that in allergen-sensitized and allergen-challenged mice, O 3 virtually doubled the numbers of eosinophils in the BAL fluid of BALB/c mice but not C57BL/6 mice (Fig 1, C and D) , indicating strain differences in the airway response.
O 3 exposure induced IL-5 release and airway eosinophilia in BALB/c but not C57BL/6 mice BALB/c mice have increased susceptibility to T H 2-mediated inflammatory conditions in comparison with C57BL/6 mice. 24 To investigate whether BALB/c mice would respond to O 3 differently without the priming effects of allergen sensitization and challenge, we further assessed these strains exposed to O 3 alone (Fig 2, A) and found that the total (Fig 2, B) and neutrophil (Fig 2, C) cell counts in BAL fluid were increased to a lesser extent in C57BL/6 mice than in BALB/c mice in response to O 3 . Furthermore, in BALB/c but not C57BL/6 mice O 3 inhalation resulted in an influx of small but significant numbers of eosinophils in the BAL fluid 12 hours later (Fig 2, D and E) together with increased IL-5 expression (Fig 2, F) . IL-5 release within the first 12 hours after O 3 exposure occurred without increased numbers or activation of T H 2 cells in the lung, as indicated by the lack of IL-4 release into the airways (data not shown) or activation of the Il4 gene promoter in the BAL cells of ''4get'' mice (data not shown).
O 3 exposure activates lung-resident ILC2s
IL-5 was produced by isolated lung ILC2s in response to addition of the epithelium-derived cytokine IL-33 (Fig 3, A) . O 3 exposure of these mice induced Il33 mRNA activation and increased protein expression in the lung tissue in a timedependent manner (Fig 3, B-D ; BALB/c data are shown). The kinetics or extent of IL-33 expression were comparable between the 2 mouse strains (Fig 3, D) . Numbers of ILC2s remained similar between air-and O 3 -exposed mice (Fig 3, E) , J ALLERGY CLIN IMMUNOL VOLUME 137, NUMBER 2 suggesting no ILC2 influx or proliferation within 12 hours after O 3 exposure.
We then isolated ILC2s from the lungs (Fig 4, A) and studied them ex vivo. qPCR showed a significantly increased activation of Il5 and Il13 mRNA 12 hours after O 3 exposure (Fig 4, B and  C) . This was evident in both strains. However, the effects were markedly greater in BALB/c ILC2s compared with C57BL/6 ILC2s. O 3 did not induce IL-5 or IL-13 production by CD4 1
Thy1
1 T H cells isolated from the lungs 12 hours after exposure, supporting that ILC2s and not T H cells were the major source of these cytokines at this early time point after O 3 inhalation.
ILC2s mediate O 3 -induced airway inflammation and AHR
To determine whether ILC2 activation in BALB/c mice is causally related to O 3 -induced airway inflammation, we treated mice with anti-Thy1.2 mAb, which depletes both innate lymphoid cells and T cells (Fig 5, A and B) , or anti-CD4 mAb, which specifically depletes CD4
1 T H cells. Anti-Thy1.2 mAb treatment significantly reduced total cell counts and neutrophilia and abolished eosinophils in the BAL fluid of O 3 -exposed BALB/c mice (Fig 5, C-E) . Anti-Thy1.2 treatment (Fig 5, F and G) but not anti-CD4 mAb treatment (Fig 5, G) abolished IL-5 release in BAL fluid of O 3 -exposed mice, confirming that innate lymphoid cells and not T H cells were likely the major source of IL-5 12 hours after exposure.
Because anti-Thy1.2 mAb treatment depletes both ILC2s and T cells, we added back Thy1.1 1 ILC2s by means of intratracheal transfer to verify the specific role of these cells in O 3 -induced airway inflammation (Fig 2, A and B) . We transferred ILC2s that were expanded in vitro with IL-2, IL-7, and IL-33. ILC2 transfer restored total and neutrophil cell counts and significantly enhanced IL-5 levels and airway eosinophilia in response to O 3 in anti-Thy1.2 mAb-treated mice (Fig 2, C-F) .
To confirm whether the effects of ILC2s had any physiologic relevance, we investigated lung function of the O 3 -exposed mice by studying their methacholine responsiveness (Fig 5, H) . AntiThy1.2 mAb treatment (pink squares) significantly reduced AHR after O 3 inhalation. Conversely, ILC2 transfer into the anti-Thy1.2 mAb-treated mice (Fig 5, H, red squares) dramatically enhanced AHR to methacholine after O 3 . Notably, ILC2 transfer did not induce spontaneous AHR in air-exposed mice (Fig 5, H, white squares) , suggesting that in vivo activation of these cells by O 3 exposure is a requirement for the physiologic effects.
DISCUSSION
In this article we describe a novel role of innate lymphoid cells in O 3 -induced acute airway inflammation and AHR. We found that O 3 exposure increased airway levels of IL-33, a potent activator of ILC2s. We showed that lung-resident ILC2s were the predominant early source of the T H 2 cytokines IL-5 and IL-13 in O 3 -exposed mice. Cell depletion and add-back experiments established an essential role of ILC2s in mediating O 3 -induced airway inflammation and AHR. Together, these data indicated that ILC2s are critical effector cells in O 3 -induced airway inflammation in mice. The heightened sensitivity of asthmatic patients in comparison with healthy subjects to air pollution, especially O 3 inhalation, is not well understood. 5, [25] [26] [27] In mouse models allergen-induced 28, 29 and O 3 -induced airway changes also vary among different strains, 7, 30 implying genetically determined pathologies. Here we mimicked exacerbation of allergic airway changes by O 3 In addition to T H 2 cells, ILC2s can also produce IL-5 when stimulated by the epithelium-derived cytokine IL-33. 10, 12, 33 Interestingly, we found that O 3 induced IL-33 expression in the lung in a time-dependent manner. This effect was comparable between BALB/c and C57BL/6 mice. The number of ILC2s did not change after O 3 exposure in either strain, suggesting that within the 12-hour time period, no ILC2 influx or proliferation took place in the lung. Notably, however, when ILC2s were isolated from the lungs, their capability to express Il5 and Il13 mRNA was significantly increased. Although both strains showed Il5 and Il13 mRNA induction, the effects were markedly greater in BALB/c ILC2s compared with C57BL/6 ILC2s. Furthermore, O 3 did not induce IL-5 or IL-13 production by CD4 1 cells, confirming that ILC2s but not T H cells were the major source of these cytokines at this early time point after O 3 inhalation. These results established that in comparison with C57BL/6 mice, BALB/c mice exhibited increased airway neutrophilia, displayed evidence of eosinophil granulocytes in the airways, and expressed heightened IL-5 levels in the BAL fluid after O 3 inhalation. Such discrepancies in O 3 responsiveness were associated with a markedly amplified activation of Il5 and Il13 mRNA in pulmonary ILC2s of BALB/c mice. Thus O 3 activated BALB/c ILC2s to a significantly greater extent than C57BL/6 ILC2s, suggesting that ILC2s in these strains are intrinsically different in their function. Therefore it is possible that ILC2 functional differences are also responsible for O 3 susceptibility in asthmatic patients.
Although recent work has made significant advances in understanding the biology of innate lymphoid cells, their functional capability remains to be better appreciated. ILC2 activation can cause asthma-related features, including airway inflammation, mucus production, and AHR. To determine whether ILC2 activation in BALB/c mice is causally related to O 3 -induced airway inflammation, we depleted both innate lymphoid cells and T cells or, specifically, CD4
1 T H cells. Depletion of ILC2s and T cells significantly reduced total cell counts and neutrophilia and abolished the presence of eosinophils in the BAL fluid of the O 3 -exposed BALB/c mice. ILC2 but not CD4 depletion abolished IL-5 release in the BAL fluid of O 3 -exposed mice, confirming that ILC2s were the source of this cytokine. ILC2s add back restored total and neutrophil cell counts and significantly enhanced IL-5 and airway eosinophilia in response to O 3 .
To investigate the physiologic relevance of the effects of ILC2s, we investigated the lung function of the O 3 -exposed mice. Because we found that O 3 heightened IL-13 induction in BALB/c ILC2s and because IL-13 can directly induce AHR, 12, 34, 35 we hypothesized that the presence of ILC2s in the lung is necessary for the O 3 -induced AHR. Indeed, ILC2 depletion significantly reduced AHR after O 3 inhalation, whereas ILC2s add back dramatically enhanced AHR after O 3 . Because ILC2 transfer did not induce spontaneous AHR in air-exposed mice, we propose that in vivo activation of these cells by O 3 exposure is a requirement for the physiologic effects.
Our data clearly demonstrated the effectiveness of activated ILC2s in altering lung physiology. The mechanism and significance of the direct ILC2 action on AHR in response to O 3 will need further clarification. Nonetheless, the facts that O 3 -activated ILC2 outcomes were disproportionately greater on methacholine responsiveness than on airway inflammation and that ILC2s can affect AHR through IL-13 during inflammatory changes in the lung 12, 35 suggest a potential direct regulatory role of these cells in airway physiology.
In summary, we identified lung-resident ILC2s as the cell type responsible for airway inflammation induced by an air pollutant. Our study suggests that ILC2s might significantly contribute to the mechanisms by which air pollution induces asthma exacerbation.
